Regeneus (ASX:RGS) secures $4.5 M for osteoarthritis trials
Clinical-stage regenerative medicine company Regeneus (RGS) has secured up to $4.5 million…
Fri, 12 Aug | Close | Change |
4:56pm | 7,032.5 | 38.5 |
Closed at Fri, 12 Aug 6:07pm |
S&P/ASX Sm. Ords. | 3,050.4 | 36.5 | 1.18% |
All Ordinaries | 7,288.8 | 36.6 | 0.50% |
S&P/ASX 100 | 5,866.1 | 27.7 | 0.47% |